Top Markets
#1 Purr Purr +54.54%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +48.78%
#4 Non-Playable Coin Non-Playable Coin +33.05%
#5 ApeX ApeX +25.72%
#6 StonkBroker StonkBroker +25.22%
#7 Kinetiq Kinetiq +24.77%
#8 Morpho Morpho +23.58%
#9 OriginTrail OriginTrail +20.15%
#10 Grass Grass +19.77%
Coin of the day
Purr Purr
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Hisse Senetlerindeki Sıralama #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Hisse Fiyatı
$2.72
Son senkronizasyon: 2023-10-19
Piyasa Değeri
$111.47M
Değişim (1 gün)
-0.73%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Talaris Therapeutics, Inc. (TALS)

Kategori

Healthcare
Talaris Therapeutics, Inc. (TALS) için gelir
Aug 2026 itibarıyla gelir TTM: 0
Talaris Therapeutics, Inc. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Talaris Therapeutics, Inc. için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH